Article
Selective HLA Class II Allele-Restricted Activation of Atabecestat Metabolite-Specific Human T-Cells.
Chemical research in toxicology - 21 Oct 2024
Ford Megan, Thomson Paul J, Snoeys Jan, Meng Xiaoli, Naisbitt Dean J
Abstract excerpt
Elevations in hepatic enzymes were detected in several trial patients exposed to the Alzheimer's drug atabecestat, which resulted in termination of the drug development program. Characterization of hepatic T-lymphocyte infiltrates and diaminothiazine (DIAT) metabolite-responsive, human leukocyte antigen (HLA)-DR-restricted, CD4+ T-lymphocytes in the blood of patients confirmed an immune pathogenesis. Patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
